However, so far across studies with GLP1R agonists , cardiovascular measurements such as blood pressure have seen improvements in general, with no significant increases in adverse cardiovascular effects seen in patients even after 2 years (In fact, decreases were seen), suggesting that the cardiovascular benefits of decreased body weight may overcome any potential harm that increases in heart rate by GLP1R agonists may cause
MedlinePlus Medical Encyclopedia
I 2 , 89%), glaucoma (HR, 0.84
Sublingual and tablet formulations are taken once daily by mouth
Various MQC-targeted therapeutic strategies, such as enhancing mitochondrial biogenesis, promoting mitophagy, and regulating mitochondrial dynamics, together with combined approaches (e.g., gene therapy, cell-based therapies, and lifestyle modifications), have demonstrated promising protective effects in preclinical OA models